{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:25:19Z","timestamp":1794270319674,"version":"4.9.0"},"reference-count":153,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700380"],"award-info":[{"award-number":["81700380"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.arr.2026.103356","type":"journal-article","created":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T06:39:47Z","timestamp":1788590387000},"page":"103356","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["CAR-based immunotherapy for cardiac fibrosis: A new therapeutic frontier"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1652-1869","authenticated-orcid":false,"given":"Na","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoming","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchong","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2026.103356_bib1","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-019-1546-z","article-title":"Targeting cardiac fibrosis with engineered T cells","volume":"573","author":"Aghajanian","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.arr.2026.103356_bib2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s42255-022-00537-5","article-title":"CAR-based therapies: opportunities for immuno-medicine beyond cancer","volume":"4","author":"Aghajanian","year":"2022","journal-title":"Nat. Metab."},{"key":"10.1016\/j.arr.2026.103356_bib3","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1038\/s41467-024-50806-y","article-title":"Tregs delivered post-myocardial infarction adopt an injury-specific phenotype promoting cardiac repair via macrophages in mice","volume":"15","author":"Alshoubaki","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2026.103356_bib4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/s41586-024-08008-5","article-title":"Targeting immune-fibroblast cell communication in heart failure","volume":"635","author":"Amrute","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.arr.2026.103356_bib5","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1101\/gad.1653708","article-title":"Role of platelet-derived growth factors in physiology and medicine","volume":"22","author":"Andrae","year":"2008","journal-title":"Genes. Dev."},{"key":"10.1016\/j.arr.2026.103356_bib6","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ejca.2021.09.016","article-title":"Contemporary dose-escalation methods for early phase studies in the immunotherapeutics era","volume":"158","author":"Araujo","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.arr.2026.103356_bib7","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/s41586-023-06243-w","article-title":"CAR T therapy beyond cancer: the evolution of a living drug","volume":"619","author":"Baker","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.arr.2026.103356_bib8","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41587-022-01294-2","article-title":"The clinical progress of mRNA vaccines and immunotherapies","volume":"40","author":"Barbier","year":"2022","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.arr.2026.103356_bib9","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.jacc.2024.10.103","article-title":"Myocardial Fibroblast Activation After Acute Myocardial Infarction: A Positron Emission Tomography and Magnetic Resonance Study","volume":"85","author":"Barton","year":"2025","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.arr.2026.103356_bib10","doi-asserted-by":"crossref","first-page":"H1015","DOI":"10.1152\/ajpheart.00023.2006","article-title":"Cardiac fibroblasts: friend or foe?","volume":"291","author":"Baudino","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.arr.2026.103356_bib11","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/s41577-025-01186-x","article-title":"The spatial and temporal activation of macrophages during fibrosis","volume":"25","author":"Behmoaras","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.arr.2026.103356_bib12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.cytogfr.2004.03.006","article-title":"Regulation of PDGF and its receptors in fibrotic diseases","volume":"15","author":"Bonner","year":"2004","journal-title":"Cytokine Growth Factor. Rev."},{"key":"10.1016\/j.arr.2026.103356_bib13","article-title":"In vivo chimeric antigen receptor (CAR)-T cell therapy","author":"Bot","year":"2025","journal-title":"Nat. Rev. Drug. Discov."},{"key":"10.1016\/j.arr.2026.103356_bib14","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s44161-022-00043-7","article-title":"Fibroblasts orchestrate cellular crosstalk in the heart through the ECM","volume":"1","author":"Bowers","year":"2022","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.arr.2026.103356_bib15","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1146\/annurev.pharmtox.45.120403.095802","article-title":"The cardiac fibroblast: therapeutic target in myocardial remodeling and failure","volume":"45","author":"Brown","year":"2005","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.arr.2026.103356_bib16","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202500970R","article-title":"Targeting Inflammation and Fibrosis in Cardiovascular Disease: Emerging Mechanisms and Therapies","volume":"39","author":"Cabrera-Fuentes","year":"2025","journal-title":"FASEB J."},{"key":"10.1016\/j.arr.2026.103356_bib17","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1093\/glycob\/cwy058","article-title":"Role of proteoglycans and glycosaminoglycans in Duchenne muscular dystrophy","volume":"29","author":"Carmen","year":"2019","journal-title":"Glycobiology"},{"key":"10.1016\/j.arr.2026.103356_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26146590","article-title":"CSPG4.CAR-T Cells Modulate Extracellular Matrix Remodeling in DMD Cardiomyopathy","volume":"26","author":"Ceraolo","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2026.103356_bib19","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1038\/s41467-025-56703-2","article-title":"CD248-targeted BBIR-T cell therapy against late-activated fibroblasts in cardiac repair after myocardial infarction","volume":"16","author":"Chen","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2026.103356_bib20","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/s41592-022-01591-3","article-title":"Challenges and opportunities for the next generation of cardiovascular tissue engineering","volume":"19","author":"Cho","year":"2022","journal-title":"Nat. Methods"},{"key":"10.1016\/j.arr.2026.103356_bib21","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s41586-025-08945-9","article-title":"Selective inhibition of stromal mechanosensing suppresses cardiac fibrosis","volume":"642","author":"Cho","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.arr.2026.103356_bib22","doi-asserted-by":"crossref","first-page":"7408","DOI":"10.1074\/jbc.M009604200","article-title":"Molecular cloning and characterization of endosialin, a C-type lectin-like cell surface receptor of tumor endothelium","volume":"276","author":"Christian","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.arr.2026.103356_bib23","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1038\/s41590-023-01659-y","article-title":"Forks in the road for CAR T and CAR NK cell cancer therapies","volume":"24","author":"Dagher","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.arr.2026.103356_bib24","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jhep.2024.01.034","article-title":"Chimeric antigen receptor-modified macrophages ameliorate liver fibrosis in preclinical models","volume":"80","author":"Dai","year":"2024","journal-title":"J. Hepatol."},{"key":"10.1016\/j.arr.2026.103356_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41569-026-01274-y","article-title":"Inflammatory signalling in diabetic cardiomyopathy: molecular mechanisms and potential therapeutic strategies","author":"De Blasio","year":"2026","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.arr.2026.103356_bib26","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41590-018-0272-2","article-title":"Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction","volume":"20","author":"Dick","year":"2019","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.arr.2026.103356_bib27","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2967\/jnumed.121.263555","article-title":"Cardiac Fibroblast Activation in Patients Early After Acute Myocardial Infarction: Integration with MR Tissue Characterization and Subsequent Functional Outcome","volume":"63","author":"Diekmann","year":"2022","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.arr.2026.103356_bib28","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1038\/s41596-021-00629-8","article-title":"Generation of heart-forming organoids from human pluripotent stem cells","volume":"16","author":"Drakhlis","year":"2021","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.arr.2026.103356_bib29","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/CIRCRESAHA.125.326716","article-title":"CAR Macrophages Engineered In Vivo for Attenuating Myocardial Ischemia-Reperfusion Injury","volume":"137","author":"Du","year":"2025","journal-title":"Circ. Res."},{"key":"10.1016\/j.arr.2026.103356_bib30","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.tcm.2019.09.003","article-title":"Current understanding of fibrosis in genetic cardiomyopathies","volume":"30","author":"Eijgenraam","year":"2020","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.arr.2026.103356_bib31","doi-asserted-by":"crossref","first-page":"186","DOI":"10.3389\/fphar.2017.00186","article-title":"A Clinical Perspective of Anti-Fibrotic Therapies for Cardiovascular Disease","volume":"8","author":"Fang","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.arr.2026.103356_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2025.101545","article-title":"FAP-CAR-T cells reduce dystrophic muscle fibrosis, improving adeno-associated virus gene transfer efficacy","volume":"33","author":"Ferrand","year":"2025","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.arr.2026.103356_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114061","article-title":"Preclinical scenario of targeting myocardial fibrosis with chimeric antigen receptor (CAR) immunotherapy","volume":"158","author":"Ferrer-Curriu","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.arr.2026.103356_bib34","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41571-022-00704-3","article-title":"Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours","volume":"20","author":"Flugel","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.arr.2026.103356_bib35","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/nrcardio.2014.28","article-title":"The inflammatory response in myocardial injury, repair, and remodelling","volume":"11","author":"Frangogiannis","year":"2014","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.arr.2026.103356_bib36","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1161\/CIRCRESAHA.119.311148","article-title":"The Extracellular Matrix in Ischemic and Nonischemic Heart Failure","volume":"125","author":"Frangogiannis","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.arr.2026.103356_bib37","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1093\/cvr\/cvaa324","article-title":"Cardiac fibrosis","volume":"117","author":"Frangogiannis","year":"2021","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.arr.2026.103356_bib38","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1016\/S0140-6736(25)01671-X","article-title":"Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China","volume":"406","author":"Gao","year":"2026","journal-title":"Lancet"},{"key":"10.1016\/j.arr.2026.103356_bib39","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/s41421-024-00718-4","article-title":"Targeting cardiac fibrosis with chimeric antigen receptor macrophages","volume":"10","author":"Gao","year":"2024","journal-title":"Cell. Discov."},{"key":"10.1016\/j.arr.2026.103356_bib40","doi-asserted-by":"crossref","first-page":"7235","DOI":"10.1073\/pnas.87.18.7235","article-title":"Cell surface glycoprotein of reactive stromal fibroblasts as a potential antibody target in human epithelial cancers","volume":"87","author":"Garin-Chesa","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2026.103356_bib41","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/s13046-023-02884-x","article-title":"CSPG4 CAR-redirected Cytokine Induced Killer lymphocytes (CIK) as effective cellular immunotherapy for HLA class I defective melanoma","volume":"42","author":"Giraudo","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.arr.2026.103356_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084883","article-title":"Diversified expression of NG2\/CSPG4 isoforms in glioblastoma and human foetal brain identifies pericyte subsets","volume":"8","author":"Girolamo","year":"2013","journal-title":"PLoS. One"},{"key":"10.1016\/j.arr.2026.103356_bib43","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1161\/CIRCULATIONAHA.117.030742","article-title":"Single-Cell Sequencing of the Healthy and Diseased Heart Reveals Cytoskeleton-Associated Protein 4 as a New Modulator of Fibroblasts Activation","volume":"138","author":"Gladka","year":"2018","journal-title":"Circulation"},{"issue":"10513","key":"10.1016\/j.arr.2026.103356_bib44","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/S0140-6736(25)01917-8","article-title":"Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990\u20112023: a systematic analysis for the Global Burden of Disease Study 2023","volume":"406","year":"2025","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.arr.2026.103356_bib45","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1016\/j.jacc.2025.08.015","article-title":"Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023","volume":"86","year":"2025","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.arr.2026.103356_bib46","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/s41388-025-03332-0","article-title":"Human CSPG4-targeting CAR-macrophages inhibit melanoma growth","volume":"44","author":"Greiner","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.arr.2026.103356_bib47","doi-asserted-by":"crossref","DOI":"10.1002\/pst.2461","article-title":"A Phase I Dose-Finding Design Incorporating Intra-Patient Dose Escalation","volume":"24","author":"Guo","year":"2025","journal-title":"Pharm. Stat."},{"key":"10.1016\/j.arr.2026.103356_bib48","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nri1256","article-title":"Dendritic cells: emerging pharmacological targets of immunosuppressive drugs","volume":"4","author":"Hackstein","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.arr.2026.103356_bib49","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1365-2567.2011.03437.x","article-title":"The stromal cell antigen CD248 (endosialin) is expressed on naive CD8+ human T cells and regulates proliferation","volume":"133","author":"Hardie","year":"2011","journal-title":"Immunology"},{"key":"10.1016\/j.arr.2026.103356_bib50","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20112764","article-title":"CSPG4-Specific CAR T Cells for High-Risk Childhood B Cell Precursor Leukemia","volume":"20","author":"Harrer","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2026.103356_bib51","first-page":"E895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.arr.2026.103356_bib52","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1152\/physrev.1999.79.4.1283","article-title":"Mechanism of action and in vivo role of platelet-derived growth factor","volume":"79","author":"Heldin","year":"1999","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.arr.2026.103356_bib53","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-020-2938-9","article-title":"Fibrosis: from mechanisms to medicines","volume":"587","author":"Henderson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.arr.2026.103356_bib54","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1056\/NEJMoa1002659","article-title":"Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy","volume":"363","author":"Ho","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2026.103356_bib55","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.ccell.2020.07.005","article-title":"Engineering CAR-T Cells for Next-Generation Cancer Therapy","volume":"38","author":"Hong","year":"2020","journal-title":"Cancer Cell."},{"key":"10.1016\/j.arr.2026.103356_bib56","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.7150\/thno.116749","article-title":"Engineered T cell therapy for the treatment of cardiac fibrosis during chronic phase of myocarditis","volume":"16","author":"Hua","year":"2026","journal-title":"Theranostics"},{"key":"10.1016\/j.arr.2026.103356_bib57","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1126\/science.ads8473","article-title":"vivo CAR T cell generation to treat cancer and autoimmune disease","volume":"388","author":"Hunter","year":"2025","journal-title":"Science"},{"key":"10.1016\/j.arr.2026.103356_bib58","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1056\/NEJMra1706169","article-title":"Chimeric Antigen Receptor Therapy","volume":"379","author":"June","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2026.103356_bib59","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1097\/HJH.0b013e328349c62d","article-title":"CD4(+)CD25(+)Foxp3(+) regulatory T cells suppress cardiac fibrosis in the hypertensive heart","volume":"29","author":"Kanellakis","year":"2011","journal-title":"J. Hypertens."},{"key":"10.1016\/j.arr.2026.103356_bib60","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms12260","article-title":"Genetic lineage tracing defines myofibroblast origin and function in the injured heart","volume":"7","author":"Kanisicak","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2026.103356_bib61","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1161\/CIRCRESAHA.117.311876","article-title":"Distinct Cellular Basis for Early Cardiac Arrhythmias, the Cardinal Manifestation of Arrhythmogenic Cardiomyopathy, and the Skin Phenotype of Cardiocutaneous Syndromes","volume":"121","author":"Karmouch","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.arr.2026.103356_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.825979","article-title":"Engineered NK Cells Against Cancer and Their Potential Applications Beyond","volume":"13","author":"Karvouni","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.arr.2026.103356_bib63","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1161\/CIRCRESAHA.116.308643","article-title":"Targeted Ablation of Periostin-Expressing Activated Fibroblasts Prevents Adverse Cardiac Remodeling in Mice","volume":"118","author":"Kaur","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.arr.2026.103356_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gene.2017.03.003","article-title":"PDGFs and their receptors","volume":"614","author":"Kazlauskas","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.arr.2026.103356_bib65","doi-asserted-by":"crossref","DOI":"10.1038\/s41569-026-01255-1","article-title":"Heart-on-a-chip and vasculature-on-a-chip platforms as models of cardiovascular disease","author":"Khosravi","year":"2026","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.arr.2026.103356_bib66","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.stem.2022.03.012","article-title":"Progress in multicellular human cardiac organoids for clinical applications","volume":"29","author":"Kim","year":"2022","journal-title":"Cell. Stem Cell."},{"key":"10.1016\/j.arr.2026.103356_bib67","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","article-title":"The pathogenesis of cardiac fibrosis","volume":"71","author":"Kong","year":"2014","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.arr.2026.103356_bib68","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1126\/science.1195300","article-title":"Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha","volume":"330","author":"Kraman","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.arr.2026.103356_bib69","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1161\/CIRCULATIONAHA.108.832782","article-title":"Regulatory T cells ameliorate angiotensin II-induced cardiac damage","volume":"119","author":"Kvakan","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.arr.2026.103356_bib70","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ni1581","article-title":"Up on the tightrope: natural killer cell activation and inhibition","volume":"9","author":"Lanier","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.arr.2026.103356_bib71","doi-asserted-by":"crossref","DOI":"10.3390\/biom11091277","article-title":"Heart Organoids and Engineered Heart Tissues: Novel Tools for Modeling Human Cardiac Biology and Disease","volume":"11","author":"Lewis-Israeli","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.arr.2026.103356_bib72","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s44161-025-00617-1","article-title":"Dynamic molecular atlas of cardiac fibrosis at single-cell resolution shows CD248 in cardiac fibroblasts orchestrates interactions with immune cells","volume":"4","author":"Li","year":"2025","journal-title":"Nat. Cardiovasc. Res."},{"key":"10.1016\/j.arr.2026.103356_bib73","article-title":"Polyphenol-Nanoengineered Monocyte Biohybrids for Targeted Cardiac Repair and Immunomodulation","volume":"14","author":"Li","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.arr.2026.103356_bib74","article-title":"Engineered immunosuppressive dendritic cells protect against cardiac remodelling","author":"Li","year":"2026","journal-title":"Nature"},{"key":"10.1016\/j.arr.2026.103356_bib75","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41577-025-01174-1","article-title":"vivo CAR engineering for immunotherapy","volume":"25","author":"Li","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.arr.2026.103356_bib76","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1126\/science.277.5323.242","article-title":"Pericyte loss and microaneurysm formation in PDGF-B-deficient mice","volume":"277","author":"Lindahl","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.arr.2026.103356_bib77","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/s41586-020-2797-4","article-title":"Cells of the adult human heart","volume":"588","author":"Litvinukova","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.arr.2026.103356_bib78","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa1910607","article-title":"Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors","volume":"382","author":"Liu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2026.103356_bib79","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.tips.2025.07.016","article-title":"Cardiac fibrosis: from mechanisms and models to medicines","volume":"46","author":"Liu","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.arr.2026.103356_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.115840","article-title":"CAR-T cells generated in vivo for the targeted treatment of myocardial fibrosis","volume":"168","author":"Liu","year":"2026","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.arr.2026.103356_bib81","article-title":"Legumain In Situ Engineering Promotes Efferocytosis of CAR Macrophage to Treat Cardiac Fibrosis","volume":"37","author":"Liu","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.arr.2026.103356_bib82","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.tcb.2021.10.002","article-title":"Mechanical communication in fibrosis progression","volume":"32","author":"Long","year":"2022","journal-title":"Trends Cell. Biol."},{"key":"10.1016\/j.arr.2026.103356_bib83","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12943-023-01723-z","article-title":"CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances","volume":"22","author":"Maalej","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.arr.2026.103356_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116604","article-title":"Targeting fibroblast activation protein with chimeric antigen receptor macrophages","volume":"230","author":"Mao","year":"2024","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.arr.2026.103356_bib85","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s41591-023-02785-8","article-title":"Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19(+) B cell tumors: a phase 1\/2 trial","volume":"30","author":"Marin","year":"2024","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2026.103356_bib86","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/path.6362","article-title":"Macrophages producing chondroitin sulfate proteoglycan-4 induce neuro-cardiac junction impairment in Duchenne muscular dystrophy","volume":"265","author":"Milan","year":"2025","journal-title":"J. Pathol."},{"key":"10.1016\/j.arr.2026.103356_bib87","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41569-022-00805-7","article-title":"Single-cell transcriptomics for the assessment of cardiac disease","volume":"20","author":"Miranda","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.arr.2026.103356_bib88","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.cardiores.2006.06.013","article-title":"Bone marrow-derived cells contribute to infarct remodelling","volume":"71","author":"Mollmann","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.arr.2026.103356_bib89","article-title":"Treatment of cardiac fibrosis: from neuro-hormonal inhibitors to CAR-T cell therapy","author":"Morfino","year":"2023","journal-title":"Heart Fail. Rev. 28 555-569"},{"key":"10.1016\/j.arr.2026.103356_bib90","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s44303-024-00053-z","article-title":"Clinical applications of fibroblast activation protein inhibitor positron emission tomography (FAPI-PET)","volume":"2","author":"Mori","year":"2024","journal-title":"Npj Imaging"},{"key":"10.1016\/j.arr.2026.103356_bib91","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/(SICI)1097-0215(19970502)71:3<383::AID-IJC14>3.0.CO;2-H","article-title":"Mouse fibroblast activation protein: molecular cloning, alternative splicing and expression in the reactive stroma of epithelial cancers","volume":"71","author":"Niedermeyer","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.arr.2026.103356_bib92","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.cytogfr.2004.03.002","article-title":"PDGF receptors-mediators of autocrine tumor growth and regulators of tumor vasculature and stroma","volume":"15","author":"Ostman","year":"2004","journal-title":"Cytokine Growth Factor. Rev."},{"key":"10.1016\/j.arr.2026.103356_bib93","first-page":"1","article-title":"Involvement of platelet-derived growth factor in disease: development of specific antagonists","volume":"80","author":"Ostman","year":"2001","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.arr.2026.103356_bib94","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.cell.2020.08.022","article-title":"Single-Cell Analyses Identify Brain Mural Cells Expressing CD19 as Potential Off-Tumor Targets for CAR-T Immunotherapies","volume":"183","author":"Parker","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.arr.2026.103356_bib95","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adk8501","article-title":"Integration mapping of cardiac fibroblast single-cell transcriptomes elucidates cellular principles of fibrosis in diverse pathologies","volume":"10","author":"Patrick","year":"2024","journal-title":"Sci. Adv."},{"key":"10.1016\/j.arr.2026.103356_bib96","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aao2731","article-title":"Constitutive and TNFalpha-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy","volume":"10","author":"Pellegatta","year":"2018","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.arr.2026.103356_bib97","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/s41569-022-00799-2","article-title":"Cardiac fibroblasts and mechanosensation in heart development, health and disease","volume":"20","author":"Pesce","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.arr.2026.103356_bib98","first-page":"785","article-title":"Expression of platelet-derived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis","volume":"148","author":"Pinzani","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.arr.2026.103356_bib99","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","article-title":"The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis","volume":"119","author":"Prabhu","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.arr.2026.103356_bib100","doi-asserted-by":"crossref","DOI":"10.1038\/s41577-026-01322-1","article-title":"A guide to CAR T cell therapies: development, current status and future prospects","author":"Rafei","year":"2026","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.arr.2026.103356_bib101","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-019-0297-y","article-title":"Engineering strategies to overcome the current roadblocks in CAR T cell therapy","volume":"17","author":"Rafiq","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.arr.2026.103356_bib102","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.2353\/ajpath.2006.060196","article-title":"Platelet-derived growth factor-beta receptor activation is essential for fibroblast and pericyte recruitment during cutaneous wound healing","volume":"169","author":"Rajkumar","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.arr.2026.103356_bib103","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2023.101194","article-title":"Cardiac Fibrosis in heart failure: Focus on non-invasive diagnosis and emerging therapeutic strategies","volume":"93","author":"Ravassa","year":"2023","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.arr.2026.103356_bib104","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1073\/pnas.85.9.3110","article-title":"Cell-surface glycoproteins of human sarcomas: differential expression in normal and malignant tissues and cultured cells","volume":"85","author":"Rettig","year":"1988","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2026.103356_bib105","first-page":"3327","article-title":"Regulation and heteromeric structure of the fibroblast activation protein in normal and transformed cells of mesenchymal and neuroectodermal origin","volume":"53","author":"Rettig","year":"1993","journal-title":"Cancer Res."},{"key":"10.1016\/j.arr.2026.103356_bib106","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1161\/CIRCRESAHA.121.319737","article-title":"Cardiac Resident Macrophages Prevent Fibrosis and Stimulate Angiogenesis","volume":"129","author":"Revelo","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.arr.2026.103356_bib107","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41551-020-0539-4","article-title":"Human cardiac organoids for the modelling of myocardial infarction and drug cardiotoxicity","volume":"4","author":"Richards","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.arr.2026.103356_bib108","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1084\/jem.20122344","article-title":"Depletion of stromal cells expressing fibroblast activation protein-alpha from skeletal muscle and bone marrow results in cachexia and anemia","volume":"210","author":"Roberts","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.arr.2026.103356_bib109","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1182\/blood-2006-04-014894","article-title":"Platelet-derived growth factor receptor-beta promotes early endothelial cell differentiation","volume":"108","author":"Rolny","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.arr.2026.103356_bib110","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1161\/CIRCRESAHA.121.318005","article-title":"Immune Cells and Immunotherapy for Cardiac Injury and Repair","volume":"128","author":"Rurik","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.arr.2026.103356_bib111","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.abm0594","article-title":"CAR T cells produced in vivo to treat cardiac injury","volume":"375","author":"Rurik","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.arr.2026.103356_bib112","doi-asserted-by":"crossref","first-page":"5657","DOI":"10.1073\/pnas.91.12.5657","article-title":"Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers","volume":"91","author":"Scanlan","year":"1994","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.arr.2026.103356_bib113","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/cts.12582","article-title":"Design and Conduct Considerations for First-in-Human Trials","volume":"12","author":"Shen","year":"2019","journal-title":"Clin. Transl. Sci."},{"key":"10.1016\/j.arr.2026.103356_bib114","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1161\/CIRCULATIONAHA.109.893248","article-title":"Regulatory T cells protect mice against coxsackievirus-induced myocarditis through the transforming growth factor beta-coxsackie-adenovirus receptor pathway","volume":"121","author":"Shi","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.arr.2026.103356_bib115","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1016\/j.cell.2024.06.028","article-title":"Innate immune memory after brain injury drives inflammatory cardiac dysfunction","volume":"187","author":"Simats","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.arr.2026.103356_bib116","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/s41419-024-06703-9","article-title":"Modeling acute myocardial infarction and cardiac fibrosis using human induced pluripotent stem cell-derived multi-cellular heart organoids","volume":"15","author":"Song","year":"2024","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.arr.2026.103356_bib117","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1161\/CIRCRESAHA.122.320781","article-title":"Inhibition of Fap Promotes Cardiac Repair by Stabilizing BNP","volume":"132","author":"Sun","year":"2023","journal-title":"Circ. Res."},{"key":"10.1016\/j.arr.2026.103356_bib118","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrcardio.2017.57","article-title":"Redefining the identity of cardiac fibroblasts","volume":"14","author":"Tallquist","year":"2017","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.arr.2026.103356_bib119","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202303267","article-title":"Genetically Engineered Macrophages Co-Loaded with CD47 Inhibitors Synergistically Reconstruct Efferocytosis and Improve Cardiac Remodeling Post Myocardial Ischemia Reperfusion Injury","volume":"13","author":"Tan","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.arr.2026.103356_bib120","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.yjmcc.2015.08.016","article-title":"Fibroblast activation protein alpha expression identifies activated fibroblasts after myocardial infarction","volume":"87","author":"Tillmanns","year":"2015","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.arr.2026.103356_bib121","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s12943-022-01672-z","article-title":"NK cells and solid tumors: therapeutic potential and persisting obstacles","volume":"21","author":"Tong","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.arr.2026.103356_bib122","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1084\/jem.20130110","article-title":"Immune targeting of fibroblast activation protein triggers recognition of multipotent bone marrow stromal cells and cachexia","volume":"210","author":"Tran","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.arr.2026.103356_bib123","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","article-title":"Cardiac Fibrosis: The Fibroblast Awakens","volume":"118","author":"Travers","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.arr.2026.103356_bib124","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1158\/0008-5472.CAN-11-3890","article-title":"A universal strategy for adoptive immunotherapy of cancer through use of a novel T-cell antigen receptor","volume":"72","author":"Urbanska","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.arr.2026.103356_bib125","doi-asserted-by":"crossref","first-page":"432","DOI":"10.2174\/138945012799424615","article-title":"CD248: reviewing its role in health and disease","volume":"13","author":"Valdez","year":"2012","journal-title":"Curr. Drug. Targets"},{"key":"10.1016\/j.arr.2026.103356_bib126","first-page":"845","article-title":"Limitations of Animal Studies for Predicting Toxicity in Clinical Trials","volume":"4","author":"Van Norman","year":"2019","journal-title":"Is. it Time Rethink. Our Curr. Approach? JACC Basic. Transl. Sci."},{"key":"10.1016\/j.arr.2026.103356_bib127","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1161\/CIRCRESAHA.124.325212","article-title":"CAR-Macrophage Therapy Alleviates Myocardial Ischemia-Reperfusion Injury","volume":"135","author":"Wang","year":"2024","journal-title":"Circ. Res."},{"key":"10.1016\/j.arr.2026.103356_bib128","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1158\/2326-6066.CIR-13-0027","article-title":"Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity","volume":"2","author":"Wang","year":"2014","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.arr.2026.103356_bib129","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1056\/NEJMc2509522","article-title":"Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus","volume":"393","author":"Wang","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2026.103356_bib130","first-page":"1068","article-title":"Overcoming Resistance and Relapse in CAR-T and CAR-NK Cell Therapies: From Bench to Bedside","volume":"9","author":"Wang","year":"2026","journal-title":"Res. (Wash. D. C. )"},{"key":"10.1016\/j.arr.2026.103356_bib131","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1161\/CIRCRESAHA.115.303895","article-title":"Foxp3+ CD4+ T cells improve healing after myocardial infarction by modulating monocyte\/macrophage differentiation","volume":"115","author":"Weirather","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.arr.2026.103356_bib132","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/ijc.2910280307","article-title":"Distribution and molecular characterization of a cell-surface and a cytoplasmic antigen detectable in human melanoma cells with monoclonal antibodies","volume":"28","author":"Wilson","year":"1981","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.arr.2026.103356_bib133","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41577-022-00732-1","article-title":"Roles of natural killer cells in immunity to cancer, and applications to immunotherapy","volume":"23","author":"Wolf","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.arr.2026.103356_bib134","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/j.immuni.2021.07.003","article-title":"Resident cardiac macrophages mediate adaptive myocardial remodeling","volume":"54","author":"Wong","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.arr.2026.103356_bib135","article-title":"Proof-of-Concept Evaluation of Primary Human FAP-CAR-NK Cells Targeting Activated Fibroblasts in Pulmonary Fibrosis","volume":"27","author":"Wu","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2026.103356_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.stem.2026.04.003","article-title":"Engineered CAR-monocytes coordinate fibrosis clearance and cardiac regeneration following myocardial infarction","author":"Wu","year":"2026","journal-title":"Cell. Stem Cell."},{"key":"10.1016\/j.arr.2026.103356_bib137","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1161\/CIRCULATIONAHA.120.046789","article-title":"A Unique Population of Regulatory T Cells in Heart Potentiates Cardiac Protection From Myocardial Infarction","volume":"142","author":"Xia","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.arr.2026.103356_bib138","doi-asserted-by":"crossref","DOI":"10.3791\/51329","article-title":"A Murine Model of Myocardial Ischemia-reperfusion Injury through Ligation of the Left Anterior Descending Artery","author":"Xu","year":"2014","journal-title":"Jove-J. Vis. Exp."},{"key":"10.1016\/j.arr.2026.103356_bib139","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1038\/s41467-025-59093-7","article-title":"Targeted immunotherapy rescues pulmonary fibrosis by reducing activated fibroblasts and regulating alveolar cell profile","volume":"16","author":"Yan","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2026.103356_bib140","doi-asserted-by":"crossref","first-page":"7996","DOI":"10.1038\/s41467-024-52221-9","article-title":"Engineered model of heart tissue repair for exploring fibrotic processes and therapeutic interventions","volume":"15","author":"Yang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2026.103356_bib141","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adx0368","article-title":"Anti-FAP CAR T cells produced in vivo reduce fibrosis and restore liver homeostasis in metabolic dysfunction-associated steatohepatitis","volume":"18","author":"Yashaswini","year":"2026","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.arr.2026.103356_bib142","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm1613","article-title":"Endothelial-to-mesenchymal transition contributes to cardiac fibrosis","volume":"13","author":"Zeisberg","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.arr.2026.103356_bib143","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCRESAHA.119.315491","article-title":"Generation of Quiescent Cardiac Fibroblasts From Human Induced Pluripotent Stem Cells for In Vitro Modeling of Cardiac Fibrosis","volume":"125","author":"Zhang","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.arr.2026.103356_bib144","article-title":"Natural Killer Cells and Current Applications of Chimeric Antigen Receptor-Modified NK-92 Cells in Tumor Immunotherapy","volume":"20","author":"Zhang","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.arr.2026.103356_bib145","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41569-024-01098-8","article-title":"Trials and tribulations of cell therapy for heart failure: an update on ongoing trials","volume":"22","author":"Zhang","year":"2025","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.arr.2026.103356_bib146","article-title":"Engineered Regulatory T Lymphocytes Promote Infarcted Heart Repair","author":"Zhang","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.arr.2026.103356_bib147","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s11060-024-04855-4","article-title":"Expression features of targets for anti-glioma CAR-T cell immunotherapy","volume":"171","author":"Zhang","year":"2025","journal-title":"J. Neurooncol"},{"key":"10.1016\/j.arr.2026.103356_bib148","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s11010-024-05134-6","article-title":"Targeting cardiac fibrosis with Chimeric Antigen Receptor-Engineered Cells","volume":"480","author":"Zhang","year":"2025","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.arr.2026.103356_bib149","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1038\/s41467-025-68033-4","article-title":"Viscoelastic hydrogel primed CAR-macrophage for pulmonary fibrosis treatment","volume":"17","author":"Zhang","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.arr.2026.103356_bib150","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.stem.2025.07.014","article-title":"Targeting ECM-producing cells with CAR-T therapy alleviates fibrosis in chronic kidney disease","volume":"32","author":"Zhao","year":"2025","journal-title":"Cell. Stem Cell."},{"key":"10.1016\/j.arr.2026.103356_bib151","article-title":"CAR-M2 immunotherapy resolves renal fibrosis via revascularization and apoptosis of profibrotic Cxcr2(+) endothelial cells","author":"Zhao","year":"2026","journal-title":"Cell. Rep. Med."},{"key":"10.1016\/j.arr.2026.103356_bib152","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114760","article-title":"Fibroblast activation protein-targeted chimeric antigen-receptor-modified NK cells alleviate cardiac fibrosis","volume":"157","author":"Zheng","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.arr.2026.103356_bib153","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1158\/0008-5472.CAN-23-1038","article-title":"Hypoxia-Responsive CAR-T Cells Exhibit Reduced Exhaustion and Enhanced Efficacy in Solid Tumors","volume":"84","author":"Zhu","year":"2024","journal-title":"Cancer Res."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156816372600348X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S156816372600348X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:15:44Z","timestamp":1794269744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S156816372600348X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":153,"alternative-id":["S156816372600348X"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2026.103356","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CAR-based immunotherapy for cardiac fibrosis: A new therapeutic frontier","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2026.103356","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103356"}}